Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis

Dig Dis Sci. 2019 Feb;64(2):591-593. doi: 10.1007/s10620-018-5356-1. Epub 2018 Nov 1.

Costanza De Maria^{1

2}, Ilaria Ghidotti^{1

2}, Federica Grillo^{2

3}, Edoardo G Giannini^{4

5}

¹ Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, No.6, 16132, Genoa, Italy.
² Ospedale Policlinico San Martino - IRCCS per l'Oncologia, Genoa, Italy.
³ Pathology Unit, Department of Surgical Sciences, University of Genoa, Genoa, Italy.
⁴ Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, No.6, 16132, Genoa, Italy. egiannini@unige.it.
⁵ Ospedale Policlinico San Martino - IRCCS per l'Oncologia, Genoa, Italy. egiannini@unige.it.

No abstract available

Keywords: Autoimmune hepatitis; Azathioprine; Cirrhosis; Direct-acting antivirals; Hepatitis C virus; Outcome.

Publication types